| Tue, Feb 9, 2010 | | • | Researchers find sex-specific lung cancer genes
at Reuters (Tue 7:34pm)
| | • | How Much Should Cancer Drugs Cost?
at The Wall Street Journal Online (Tue 4:05pm)
| | • | Make Thousands From Millions
at Motley Fool (Tue 1:20pm)
| | Mon, Feb 8, 2010 | | • | UPDATE - U.S. FDA staff questions small ChemGenex study
at Reuters (Mon, Feb 8)
| | • | UK says Novartis, Bristol cancer drugs too costly
at Reuters (Mon, Feb 8)
| | • | Monday Options Recap: Volatility Eases
at Seeking Alpha (Mon, Feb 8)
| | • | Correction is Healthy - and a Buying Opportunity: Strategist
at CNBC (Mon, Feb 8)
| | • | AMRI reports $19M net loss in 4Q
at bizjournals.com (Mon, Feb 8)
| | • | UPDATE - U.S. FDA staff questions small ChemGenex study
at Reuters (Mon, Feb 8)
| | Sun, Feb 7, 2010 | | • | How Big Pharma Got in This Fix
at Seeking Alpha (Sun, Feb 7)
| | Fri, Feb 5, 2010 | | • | Bristol-Myers Squibb to freeze salaries in 2010
AP (Fri, Feb 5)
| | • | Stalled Health Care Bill Leaves Drug Makers in Regulatory Limbo
at The New York Times (Fri, Feb 5)
| | • | Why Pharma's Patent Cliff Is Good News for Pharmacies
at The Wall Street Journal Online (Fri, Feb 5)
| | Thu, Feb 4, 2010 | | • | [$$] Cost Cutting Boosts Profits
at The Wall Street Journal Online (Thu, Feb 4)
| | • | A Drugless Drugmaker IPO!
at Motley Fool (Thu, Feb 4)
| | • | Surfing the Wave of the Future: Personalized Medicine
at Motley Fool (Thu, Feb 4)
| | • | You'll Need Even More Than You Think
at Motley Fool (Thu, Feb 4)
| | • | Bristol's Entrepreneurial Thief?
at CNBC (Thu, Feb 4)
| | • | 3 Stocks That Just Make Sense
at Motley Fool (Thu, Feb 4)
| | • | Alkermes Testing Schizophrenia Drug
at TheStreet.com (Thu, Feb 4)
|
Add BMY News to My Yahoo!:
 
| |
|
1.52% Nasdaq 0.00%
Headlines
